Pharmafile Logo

Accelerating patient recruitment post-COVID-19

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

In a recent webinar Kate Shaw,Innovative Trials’ Founder & CEO,  Whitney Taynton, Unit Head at Innovative Trials, and Jane Thurston, Senior Patient Recruitment Lead for Parexel, discussed strategies for accelerating patient recruitment in clinical trials post-COVID-19 that will satisfy both sites and sponsors.

Read more here

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Retention Patch Program

A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies

Innovative Trials recognised at the PMEA Awards 2023 Gala Dinner

Global patient recruitment Innovative Trials took part of the PMEA Awards gala dinner alongside the best players in the pharmaceutical industry.

Innovative Trials launches the Retention Patch Program

Innovative Trials has unveiled a new partnership with the non-profit Oliver Patch Project to boost retention in pediatric studies.

Innovative Trials at the 2023 Lloyds Bank British Business Excellence Awards

Innovative Trials achievements recognized at the Lloyds Bank British Business Excellence Awards

Innovative Trials has been shortlisted in the PMEA Awards

Innovative Trials finalist in the Support Agency of the Year at the annual PMEA industry awards.

A New Era in Patient Recruitment & Retention

Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention .

Navigator - Revolutionize your patient recruitment and retention

Welcome to the new era in patient recruitment and retention

Innovative Trials partner with Great Ormond Street Hospital Children’s Charity

The patient recruitment company has chosen their UK charity partner for 2022/2023